CHI3L1 and cancer: It is expected that it could also contribute to the treatment of not only inflammation but also cancer by inhibiting CHI3L1 expression in multiple ways including anti-CHI3L1 specific antibodies, methylxanthine derivatives, and chitin microparticles.